A randomized controlled trial has demonstrated clinically meaningful improvements in motor recovery for chronic stroke survivors using the FDA-cleared IpsiHand® brain-computer interface system.
Researchers at Washington University in St. Louis are developing a hair-thin, fiber-based implant to study how Alzheimer’s disease progresses deep within the brain. Supported by a $3.27 million NIH grant, the technology enables long-term imaging and targeted intervention in the hippocampus — one of the first regions affected in Alzheimer’s.
A randomized controlled trial has demonstrated clinically meaningful improvements in motor recovery for chronic stroke survivors using the FDA-cleared IpsiHand® brain-computer interface system.
By combining advanced vision-language AI models with real-world task analysis, researchers developed a system that can recognize cognitive sequencing errors during everyday activities like cooking. This approach moves beyond traditional assessments, offering a more realistic way to support safety, confidence, and daily functioning.
By combining advanced vision-language AI models with real-world task analysis, researchers developed a system that can recognize cognitive sequencing errors during everyday activities like cooking. This approach moves beyond traditional assessments, offering a more realistic way to support safety, confidence, and daily functioning.
Research from WashU Medicine reports encouraging long-term results for tofersen, an FDA-approved therapy for a rare genetic form of ALS caused by SOD1 mutations. Extended treatment slowed disease progression and improved survival, with about one-quarter of participants experiencing stabilization or gains in strength and mobility.
Research at Washington University in St. Louis has been recognized on the global stage, with WashU named a Focused Ultrasound Center of Excellence by the Focused Ultrasound Foundation.
NEURO360-aligned research led by Rohit V. Pappu, PhD, with Min Kyung Shinn, PhD, at WashU’s McKelvey School of Engineering is uncovering new therapeutic targets for neurodegenerative disorders such as ALS.
A randomized controlled trial has demonstrated clinically meaningful improvements in...
Read More
Researchers at Washington University in St. Louis are developing a...
Read More
A randomized controlled trial has demonstrated clinically meaningful improvements in...
Read More
By combining advanced vision-language AI models with real-world task analysis,...
Read More
By combining advanced vision-language AI models with real-world task analysis,...
Read More
Research from WashU Medicine reports encouraging long-term results for tofersen,...
Read More
Research at Washington University in St. Louis has been recognized...
Read More
NEURO360-aligned research led by Rohit V. Pappu, PhD, with Min...
Read More
ShiNung Ching, PhD, co-lead of NEURO360’s Mobile Apps, Software &...
Read More
A randomized controlled trial has demonstrated clinically meaningful improvements in motor recovery for chronic stroke survivors using the FDA-cleared IpsiHand® brain-computer interface system.
Researchers at Washington University in St. Louis are developing a hair-thin, fiber-based implant to study how Alzheimer’s disease progresses deep within the brain. Supported by a $3.27 million NIH grant, the technology enables long-term imaging and targeted intervention in the hippocampus — one of the first regions affected in Alzheimer’s.
A randomized controlled trial has demonstrated clinically meaningful improvements in motor recovery for chronic stroke survivors using the FDA-cleared IpsiHand® brain-computer interface system.
By combining advanced vision-language AI models with real-world task analysis, researchers developed a system that can recognize cognitive sequencing errors during everyday activities like cooking. This approach moves beyond traditional assessments, offering a more realistic way to support safety, confidence, and daily functioning.
By combining advanced vision-language AI models with real-world task analysis, researchers developed a system that can recognize cognitive sequencing errors during everyday activities like cooking. This approach moves beyond traditional assessments, offering a more realistic way to support safety, confidence, and daily functioning.
Research from WashU Medicine reports encouraging long-term results for tofersen, an FDA-approved therapy for a rare genetic form of ALS caused by SOD1 mutations. Extended treatment slowed disease progression and improved survival, with about one-quarter of participants experiencing stabilization or gains in strength and mobility.
Research at Washington University in St. Louis has been recognized on the global stage, with WashU named a Focused Ultrasound Center of Excellence by the Focused Ultrasound Foundation.
NEURO360-aligned research led by Rohit V. Pappu, PhD, with Min Kyung Shinn, PhD, at WashU’s McKelvey School of Engineering is uncovering new therapeutic targets for neurodegenerative disorders such as ALS.
ShiNung Ching, PhD, co-lead of NEURO360’s Mobile Apps, Software & Computing Research Node and a professor of neuroengineering, has been named chair of the Preston M. Green Department of Electrical & Systems Engineering at Washington University in St. Louis.
The Q4 edition of the NEURO360 newsletter highlights key findings …
Over the past year, the NEURO360 team worked with its …
NEURO360‑aligned research by Muriah D. Wheelock and Brian A. Gordon at WashU Medicine received a $5 million NIH grant to study how early‑life stress affects brain aging and Alzheimer’s.